FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2623735481> ?p ?o ?g. }

• W2623735481 endingPage "1034" @default.
• W2623735481 startingPage "1027" @default.
• W2623735481 abstract "Medication-related issues associated with adherence to long-term tyrosine kinase inhibitors for controlling chronic myeloid leukemia: a qualitative study Bee Kim Tan,1,2 Seng Beng Tan,3 Li-Chia Chen,4 Kian Meng Chang,5 Siew Siang Chua,1,6 Sharmini Balashanker,7 Habiba Nazeera Begum Kamarul Jaman,5 Syed Carlo Edmund,8 Ping Chong Bee3 1Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; 2Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur, Malaysia; 3Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; 4Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK; 5Department of Hematology, Ampang Hospital, Ampang, Selangor, Malaysia; 6School of Pharmacy, Faculty of Health and Medical Sciences, Taylor’s University, Lakeside Campus, Subang, Selangor, Malaysia; 7School of Pharmacy, University of Nottingham Malaysia Campus, Semenyih, Selangor, Malaysia; 8Clinical Research Center, Ampang Hospital, Ampang, Selangor, Malaysia Purpose: Poor adherence to tyrosine kinase inhibitors (TKIs) could compromise the control of chronic myeloid leukemia (CML) and contributes to poorer survival. Little is known about how medication-related issues affect CML patients’ adherence to TKI therapy in Malaysia. This qualitative study aimed to explore these issues.Patients and methods: Individual face-to-face, semistructured interviews were conducted at the hematology outpatient clinics of two medical centers in Malaysia from August 2015 to January 2016. CML patients aged ≥18 years who were prescribed a TKI were invited to participate in the study. Interviews were audio-recorded, transcribed verbatim, and thematically analyzed.Results: Four themes were identified from 18 interviews: 1) concerns about adverse reactions to TKIs, 2) personal beliefs regarding the use of TKIs, 3) mismanagement of TKIs in daily lives, and 4) financial burden in accessing treatment. Participants skipped their TKIs due to ineffective emesis control measures and perceived wastage of medication from vomiting. Participants also modified their TKI therapy due to fear of potential harm from long-term use, and stopped taking their TKIs based on belief in curative claims of traditional medicines and misconception about therapeutic effects of TKIs. Difficulty in integrating the dosing requirements of TKIs into daily lives led to unintentional skipping of doses, as well as the risk of toxicities from inappropriate dosing intervals or food interactions. Furthermore, financial constraints also resulted in delayed initiation of TKIs, missed clinic appointments, and treatment interruptions.Conclusion: Malaysian CML patients encountered a range of medication-related issues leading to a complex pattern of nonadherence to TKI therapy. Further studies should investigate whether regular contact with patients to improve understanding of treatment rationale, to elicit and address patients’ concerns about adverse reactions, and to empower patients with skills to self-manage their medications might promote better adherence to TKIs and improve CML patients’ outcome. Keywords: medication-related issues, adherence, tyrosine kinase inhibitors, chronic myeloid leukemia, qualitative study, thematic analysis" @default.
• W2623735481 created "2017-06-15" @default.
• W2623735481 creator A5002911550 @default.
• W2623735481 creator A5011013003 @default.
• W2623735481 creator A5015553459 @default.
• W2623735481 creator A5022618916 @default.
• W2623735481 creator A5039137546 @default.
• W2623735481 creator A5039296199 @default.
• W2623735481 creator A5076556621 @default.
• W2623735481 creator A5083177735 @default.
• W2623735481 creator A5084028538 @default.
• W2623735481 date "2017-06-01" @default.
• W2623735481 modified "2023-10-14" @default.
• W2623735481 title "Medication-related issues associated with adherence to long-term tyrosine kinase inhibitors for controlling chronic myeloid leukemia: a qualitative study" @default.
• W2623735481 cites W1210836019 @default.
• W2623735481 cites W1606656369 @default.
• W2623735481 cites W1981841278 @default.
• W2623735481 cites W1992446860 @default.
• W2623735481 cites W2015232510 @default.
• W2623735481 cites W2024000841 @default.
• W2623735481 cites W2026825253 @default.
• W2623735481 cites W2032936189 @default.
• W2623735481 cites W2040192752 @default.
• W2623735481 cites W2053873258 @default.
• W2623735481 cites W2055984978 @default.
• W2623735481 cites W2064367288 @default.
• W2623735481 cites W2068508150 @default.
• W2623735481 cites W2074015360 @default.
• W2623735481 cites W2085028749 @default.
• W2623735481 cites W2095068664 @default.
• W2623735481 cites W2099808933 @default.
• W2623735481 cites W2117356576 @default.
• W2623735481 cites W2123189323 @default.
• W2623735481 cites W2127866709 @default.
• W2623735481 cites W2138336376 @default.
• W2623735481 cites W2147854328 @default.
• W2623735481 cites W2152680984 @default.
• W2623735481 cites W2166270808 @default.
• W2623735481 cites W2168525672 @default.
• W2623735481 cites W2277158667 @default.
• W2623735481 cites W2284764867 @default.
• W2623735481 cites W2320591117 @default.
• W2623735481 cites W2397791882 @default.
• W2623735481 cites W2415913839 @default.
• W2623735481 cites W2434240198 @default.
• W2623735481 doi "https://doi.org/10.2147/ppa.s132894" @default.
• W2623735481 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5476765" @default.
• W2623735481 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28652712" @default.
• W2623735481 hasPublicationYear "2017" @default.
• W2623735481 type Work @default.
• W2623735481 sameAs 2623735481 @default.
• W2623735481 citedByCount "14" @default.
• W2623735481 countsByYear W26237354812018 @default.
• W2623735481 countsByYear W26237354812019 @default.
• W2623735481 countsByYear W26237354812020 @default.
• W2623735481 countsByYear W26237354812021 @default.
• W2623735481 countsByYear W26237354812022 @default.
• W2623735481 countsByYear W26237354812023 @default.
• W2623735481 crossrefType "journal-article" @default.
• W2623735481 hasAuthorship W2623735481A5002911550 @default.
• W2623735481 hasAuthorship W2623735481A5011013003 @default.
• W2623735481 hasAuthorship W2623735481A5015553459 @default.
• W2623735481 hasAuthorship W2623735481A5022618916 @default.
• W2623735481 hasAuthorship W2623735481A5039137546 @default.
• W2623735481 hasAuthorship W2623735481A5039296199 @default.
• W2623735481 hasAuthorship W2623735481A5076556621 @default.
• W2623735481 hasAuthorship W2623735481A5083177735 @default.
• W2623735481 hasAuthorship W2623735481A5084028538 @default.
• W2623735481 hasBestOaLocation W26237354811 @default.
• W2623735481 hasConcept C104863432 @default.
• W2623735481 hasConcept C126322002 @default.
• W2623735481 hasConcept C144024400 @default.
• W2623735481 hasConcept C144133560 @default.
• W2623735481 hasConcept C160735492 @default.
• W2623735481 hasConcept C162324750 @default.
• W2623735481 hasConcept C162853370 @default.
• W2623735481 hasConcept C190248442 @default.
• W2623735481 hasConcept C2778729363 @default.
• W2623735481 hasConcept C3018591125 @default.
• W2623735481 hasConcept C3020110884 @default.
• W2623735481 hasConcept C36289849 @default.
• W2623735481 hasConcept C50522688 @default.
• W2623735481 hasConcept C512399662 @default.
• W2623735481 hasConcept C556039675 @default.
• W2623735481 hasConcept C71924100 @default.
• W2623735481 hasConceptScore W2623735481C104863432 @default.
• W2623735481 hasConceptScore W2623735481C126322002 @default.
• W2623735481 hasConceptScore W2623735481C144024400 @default.
• W2623735481 hasConceptScore W2623735481C144133560 @default.
• W2623735481 hasConceptScore W2623735481C160735492 @default.
• W2623735481 hasConceptScore W2623735481C162324750 @default.
• W2623735481 hasConceptScore W2623735481C162853370 @default.
• W2623735481 hasConceptScore W2623735481C190248442 @default.
• W2623735481 hasConceptScore W2623735481C2778729363 @default.
• W2623735481 hasConceptScore W2623735481C3018591125 @default.
• W2623735481 hasConceptScore W2623735481C3020110884 @default.
• W2623735481 hasConceptScore W2623735481C36289849 @default.
• W2623735481 hasConceptScore W2623735481C50522688 @default.

• next